Outcomes of children exposed in utero to chemotherapy for breast cancer

Breast Cancer Research

Volumn 16, Issue 1, 2014, Pages

  Murthy, Rashmi K ^a   Theriault, Richard L ^a   Barnett, Chad M ^a   Hodge, Silvia ^a   Ramirez, Mildred M ^b   Milbourne, Andrea ^a,b   Rimes, Sue A ^a   Hortobagyi, Gabriel N ^a   Valero, Vicente ^a   Litton, Jennifer K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; ANTINEOPLASTIC AGENT;

ADVERSE OUTCOME; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CHILD; CLUBFOOT; CONGENITAL DISORDER; DOWN SYNDROME; FEMALE; FOLLOW UP; HUMAN; LABOR; MAJOR CLINICAL STUDY; NEWBORN DISEASE; PREGNANT WOMAN; PROSPECTIVE STUDY; VESICOURETERAL REFLUX; ADULT; BREAST NEOPLASMS; CONGENITAL ABNORMALITIES; MALE; NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PRENATAL EXPOSURE; RETROSPECTIVE STUDY; VESICO-URETERAL REFLUX;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHILD; CLUBFOOT; CONGENITAL ABNORMALITIES; CYCLOPHOSPHAMIDE; DOWN SYNDROME; DOXORUBICIN; FEMALE; FLUOROURACIL; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PRENATAL EXPOSURE DELAYED EFFECTS; RETROSPECTIVE STUDIES; VESICO-URETERAL REFLUX;

EID: 84924236099     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/s13058-014-0500-0     Document Type: Article

References (30)

1. Wallack MK, Wolf JA Jr, Bedwinek J, Denes AE, Glasgow G, Kumar B, Meyer JS, Rigg LA, Wilson-Krechel S: Gestational carcinoma of the female breast. Curr Probl Cancer 1983, 7:1-58.
2. Lethaby AE, O'Neill MA, Mason BH, Holdaway IM, Harvey VJ, the Auckland Breast Cancer Study Group: Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Int J Cancer 1996, 67:751-755.
3. Andersson TM, Johansson AL, Hsieh CC, Cnattingius S, Lambe M: Increasing incidence of pregnancy-associated breast cancer in Sweden. Obstet Gynecol 2009, 114:568-572.
4. Martin JA, Hamilton BE, Ventura SJ, Osterman MJK, Kirmeyer S, Mathews TJ, Wilson EC: Births: final data for 2009. Natl Vital Stat Rep 2011, 60(1):1-70.
5. Matthews TJ, Hamilton BE: Delayed childbearing: more women are having their first child later in life, NCHS Data Brief (No. 21). Hyattsville, MD: National Center for Health Statistics; 2009.
6. Theriault R, Hahn K: Management of breast cancer in pregnancy. Curr Oncol Rep 2007, 9:17-21.
7. Gwyn K: Children exposed to chemotherapy in utero. J Natl Cancer Inst Monogr 2005, 34:69-71.
8. Middleton LP, Amin M, Gwyn K, Theriault R, Sashin A: Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer 2003, 98:1055-1060.
9. Litton JK, Theriault RL: Breast cancer and pregnancy: current concepts in diagnosis and treatment. Oncologist 2010, 15:1238-1247.
10. Amant F, von Minckwitz G, Han SN, Bontenbal M, Ring AE, Giermek J, Wildiers H, Fehm T, Linn SC, Schlehe B, Neven P, Westenend PJ, Müller V, Van Calsteren K, Rack B, Nekliludova V, Harbeck N, Untch M, Witteveen PO, Schwedler K, Thomssen C, Van Calster B, Loibl: Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol 2013, 31:2532-2539.
11. Beadle BM, Woodward WA, Middleton LP, Tereffe W, Strom EA, Litton JK, Meric-Bernstam F, Theriault RL, Buchholz TA, Perkins GH: The impact of pregnancy on breast cancer outcomes in women ≤35 years. Cancer 2009, 115:1174-1184.
12. Litton JK, Warneke CL, Hahn KM, Palla SL, Kuerer HM, Perkins GH, Mittendorf EA, Barnett C, Gonzalez-Angulo AM, Hortobágyi GN, Theriault RL: Case control study of women treated with chemotherapy for breast cancer during pregnancy as compared with nonpregnant patients with breast cancer. Oncologist 2013, 18:369-376.
13. Berry DL, Theriault RL, Holmes FA, Parisi VM, Booser DJ, Singletary SE, Buzdar AU, Hortobagyi GN: Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 1999, 17:855-861.
14. Ring AE, Smith IE, Jones A, Shannon C, Galani E, Ellis PA: Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol 2005, 23:4192-4197.
15. Centers for Disease Control and Prevention, National Center for Health Statistics: Birth Defects: Data & Statistics. [http://www.cdc.gov/ncbddd/birthdefects/data.html ] (accessed 5 January 2015).
16. Cardonick E, Dougherty R, Grana G, Gilmandyar D, Ghaffar S, Usmani A: Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J 2010, 16:76-82.
17. Doll DC, Ringenberg QS, Yarbro JW: Antineoplastic agents and pregnancy. Semin Oncol 1989, 16:337-346.
18. Hahn KM, Johnson PH, Gordon N, Kuerer H, Middleton L, Ramirez M, Yang W, Perkins G, Hortobagyi, Theriault RL: Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 2006, 107:1219-1226.
19. Loibl S, Han SN, von Minckwitz G, Bontenbal M, Ring A, Giermek J, Fehm T, Van Calsteren K, Linn SC, Schlehe B, Gziri MM, Westenend PJ, Müller V, Heyns L, Rack B, Van Calster B, Harbeck N, Lenhard M, Halaska MJ, Kaufmann M, Nekljudova V, Amant F: Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol 2012, 13:887-896.
20. Mir O, Berveiller P, Goffinet F, Treluyer JM, Serreau R, Goldwasser F, Rouzier R: Taxanes for breast cancer during pregnancy: a systematic review. Ann Oncol 2010, 21:425-426.
21. Cardonick E, Bhat A, Gilmandyar D, Somer R: Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature. Ann Oncol 2012, 23:3016-3023.
22. Center for Disease Control and Prevention. National Center for Health Statistics. Vitalstats. http://www.cdc.gov/nchs/vitalstats.htm Accessed: 5/25/2011.
23. Lardhi AA: Prevalence and clinical significance of heart murmurs detected in routine neonatal examination. J Saudi Heart Assoc 2010, 22:25-27.
24. Simons K: Amblyopia characterization, treatment, and prophylaxis. Surv Ophthalmol 2005, 50:123-166.
25. Jallon P, Latour P: Epidemiology of idiopathic generalized epilepsies. Epilepsia 2005, 46(Suppl 9):10-14.
26. Lanphear BP, Byrd RS, Auinger P, Hall CB: Increasing prevalence of recurrent otitis media among children in the United States. Pediatrics 1997, 99:E1.
27. Nelson SP, Chen EH, Syniar GM, Christoffel KK, the Pediatric Practice Research Group: Prevalence of symptoms of gastroesophageal reflux during childhood: a pediatric practice-based survey. Arch Pediatr Adolesc Med 2000, 154:150-154.
28. Amant F, Van Calsteren K, Halaska MJ, Gziri MM, Hui W, Lagae L, Willemsen MA, Kapusta L, Van Calster B, Wouters H, Heyns L, Han SN, Tomek V, Mertens L, Ottevanger PB: Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol 2012, 13:256-264.
29. National Toxicology Program, US Department of Health and Human Services: NTP Monograph: Developmental Effects and Pregnancy Outcomes Associated with Cancer Chemotherapy Use during Pregnancy. Research Triangle Park, NC: National Institute of Environmental Health Sciences; 13 May 2013.
30. Avíles A, Neri N: Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2001, 2:173-177.